InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Mazelsky Jonathan Jay. Officer active across 2 companies, notably Idexx Laboratories INC /de. Aggregated, 42 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €2m. History available since 18 May 2021. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mazelsky Jonathan Jay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
10,000 sharesCommon StockSEC:0000818479-26-000210:0
22,822 shares0Common StockSEC:0000818479-26-000188:0
23,326 shares@ US$141.6023.4% of flowCommon StockSEC:0000874716-26-000043:0
958 shares0Common StockSEC:0000874716-26-000024:0
395.158 shares0Common StockSEC:0000818479-26-000035:0
359.576 shares0Common StockSEC:0000818479-25-000215:0
1,051 shares0Common StockSEC:0000874716-25-000152:0
183 shares@ US$598.4881.0% of flowCommon StockSEC:0000874716-25-000134:0
29,260 shares@ US$67.8518.6% of flowCommon StockSEC:0000874716-25-000126:0
279.347 shares0Common StockSEC:0000818479-25-000129:0
13,880 shares0Common StockSEC:0001127602-25-015713:0
147.727 shares0Common StockSEC:0001127602-25-012078:0
689 shares0Common StockSEC:0000874716-25-000027:0
115.474 shares0Common StockSEC:0001127602-25-001224:0
80.378 shares0Common StockSEC:0001127602-24-025512:0
384 shares0Common StockSEC:0000874716-24-000122:0
86.725 shares0Common StockSEC:0001127602-24-020398:0
7,994 shares0Common StockSEC:0001127602-24-016577:0
26.426 shares0Common StockSEC:0001127602-24-012906:0
550 shares0Common StockSEC:0000874716-24-000061:0
483 shares@ US$206.941.0% of flowCommon StockSEC:0000874716-24-000058:0
435 shares0Common StockSEC:0000874716-24-000039:0
12,000 shares@ US$67.858.1% of flowCommon StockSEC:0000874716-24-000014:0
21.479 shares0Common StockSEC:0001127602-24-001316:0
13,424 shares@ US$79.5410.5% of flowCommon StockSEC:0000874716-23-000141:0
25 of 42 declarations
About Mazelsky Jonathan Jay
MAZELSKY JONATHAN JAY is linked to Idexx Laboratories INC /de as President and CEO and to DENTSPLY SIRONA Inc. as Director. He has 42 filings, and the recent filings tracked run from 2021-05-20 to 2026-06-15, with EUR 0 in buys and EUR 1966233 in sells, and the most common transaction nature being Levée d'options.
